Skip to main content
. 2021 Mar 5;558:13–21. doi: 10.1016/j.virol.2021.02.002

Table 2.

Individual characteristics of the COVID-19 recovered subjects.

Subject number Age Gender (Male,M Female,F) Days Post PCR Diagnosis SARS CoV-2 RBD specific Immunoglobulin titersa
SARS Cov-2 whole Virus specific IgG ELISA valuesb Neutralization titer (FRNT-mNG50)c
IgG IgM IgA
1 23 M 84 2220 565 220 26 39
2 22 F 84 354 283 <100 3 26
3 68 M 40 464 <100 <100 19 <20
4 35 M 51 4547 393 545 6 113
5 50 M 37 1354 301 275 7 81
6 29 M 34 <100 866 <100 <1.5 <20
7 27 M 34 422 104 450 <1.5 <20
8 25 M 34 222 1031 <100 26 <20
9 21 M 40 650 588 153 9 25
10 39 M 38 612 539 5686 12 23
11 46 M 38 2011 325 224 24 55
12 31 M 38 494 828 183 10 <20
13 20 M 41 944 274 <100 14 49
14 36 M 41 228 279 1614 <1.5 <20
15 34 M 44 282 302 <100 4 <20
16 70 M 44 1250 220 518 14 43
17 40 M 45 464 112 101 16 <20
18 32 M 41 867 381 399 <1.5 <20
19 57 M 45 1069 354 231 <1.5 <20
20 27 F 49 1935 528 <100 23 80
21 36 M 49 3156 355 593 28 166
22 24 M 45 <100 387 <100 <1.5 <20
23 55 F 45 <100 778 <100 <1.5 <20
24 15 M 45 212 496 <100 <1.5 <20
25 49 M 45 4183 2958 397 17 657
26 26 M 48 2352 <100 <100 16 48
27 54 F 54 1202 <100 182 15 49
28 53 M 52 799 197 417 12 <20
29 52 M 48 2611 249 157 23 46
30 45 M 62 1490 401 <100 15 50
31 52 M 56 10,127 421 437 21 434
32 26 M 47 <100 <100 <100 <1.5 <20
33 32 M 57 701 177 <100 14 <20
34 44 M 49 815 428 <100 20 <20
35 32 M 40 829 140 <100 6 29
36 44 M 42 4685 494 295 26 167
37 22 M 77 3954 764 690 24 209
38 49 M 25 24,484 2828 459 22 682
39 55 M 51 371 753 <100 17 <20
40 36 M 51 621 350 104 17 <20
41 60 M 51 156 459 <100 17 34
42 62 M 47 467 354 <100 6 <20
a

ELISA end point titre limit of detection is 100.

b

ELISA was performed with a commercial kit (Covid Kavach, Zydus) using 1:100 dilution of plasma as per by the manufacturer's recommendation. Assay cut off is 1.5.

c

Neutralization titres: Neutralization assay were performed using 3 fold dilution of plasma, starting at 1:20 up to 1:43,740. Limit of detection for FRNT-mNG50 is 20.